Top

Published in:

01-10-2009 | Research Articles

How to deal with prognostic factors and radiotherapy results in uterine neoplasms with a sarcomatous component?

Authors: Ángeles Rovirosa, Carlos Ascaso, Jaume Ordi, Meritxell Arenas, Izaskun Valduvieco, José-Antonio Lejarcegui, Jaume Pahisa, Aureli Torne, Albert Biete

Published in: Clinical and Translational Oncology | Issue 10/2009

Title: How to deal with prognostic factors and radiotherapy results in uterine neoplasms with a sarcomatous component?
Authors: Ángeles Rovirosa
Carlos Ascaso
Jaume Ordi
Meritxell Arenas
Izaskun Valduvieco
José-Antonio Lejarcegui
Jaume Pahisa
Aureli Torne
Albert Biete
Publication date: 01-10-2009
Publisher: Springer Milan
Published in: Clinical and Translational Oncology / Issue 10/2009
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI: https://doi.org/10.1007/s12094-009-0424-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 10/2009

Extrapulmonary small cell carcinoma in breast and prostate

Loco-regional control after postoperative radiotherapy for patients with regional nodal metastases from melanoma

Choroidal metastases from lung adenocarcinoma

Radiosurgery and whole brain therapy in the treatment of brainstem metastases

Plasmacytoid lymphoma treated with rituximab as first-line monotherapy

Oncologic summa

Keynote webinar | Spotlight on antibody–drug conjugates in cancer